Intralymphatic immunotherapy (ILIT) is a specialized form of allergy immunotherapy designed to deliver allergens directly into lymph nodes, where immune responses are coordinated.
This targeted approach differs fundamentally from traditional subcutaneous allergy shots. AllerPoint provides intralymphatic immunotherapy (ILIT) for patients in Richmond, Northern Virginia, and surrounding regions seeking an alternative to traditional allergy shot.


These images illustrate how ultrasound is used during ILIT to locate superficial lymph nodes and guide accurate allergen delivery during treatment.
This section outlines the evaluation, planning, treatment, and monitoring steps involved in intralymphatic immunotherapy (ILIT), providing an overview of what patients can expect before, during, and after treatment.
This comparison outlines the key differences between ILIT and traditional allergy shots, focusing on treatment delivery, frequency, and overall time commitment.
The following questions address common topics related to intralymphatic immunotherapy (ILIT), treatment eligibility, and what patients can expect throughout the evaluation and treatment process.
Yes. ILIT uses low doses of allergen extract, and real-time ultrasound guidance ensures precise placement inside the lymph node. Most patients experience only mild, temporary soreness at the injection site.
Most visits take less than 15 minutes, followed by an hour of observation in the waiting room.
Patients may begin to feel relief after the third injection, with benefits continuing to build over time.
Studies suggest that relief can last for many years, similar to traditional allergy shots. Booster injections may be considered if symptoms gradually return.
Insurance plans do not typically cover ILIT because it is considered an off-label therapy. We accept multiple forms of payment, including HSA and FSA.
No. ILIT differs in both delivery method and treatment schedule. Traditional allergy shots are administered subcutaneously over several years, while ILIT involves targeted lymph node injections over a shorter period.
Yes. ILIT is designed as an alternative approach that reduces the long-term time burden associated with traditional immunotherapy.

AllerPoint provides physician-led allergy evaluation and immunotherapy. Information on this website does not replace medical consultation.
Richmond Location
9920 Independence Park Drive Suite 100
Henrico, VA 23233
Arlington Location
4850 31st St. S, Suite B
Arlington, VA 22206
(804) 280-6371
info@allerpoint.com